MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%
SelectQuote, Inc.
SLQT Details
SelectQuote, Inc. (NYSE: SLQT) is a technology-driven direct-to-consumer (DTC) distribution platform that connects individuals with a curated panel of the nation's top insurance carriers to shop for sophisticated senior health, life, and auto & home insurance products. In addition, the company's platform gathers and uses its experience to improve upon the millions of data points that feed its marketing algorithms, allowing it to allocate marketing budgets better and target more high-quality customer leads in the future.
Latest News:
Q1FY22 Results:
Key Risks:
Valuation Methodology: Price/Earnings Multiple Based Relative Valuation
(Analysis by Kalkine Group)
SLQT Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
SLQT's stock price has fallen 60.83% in the past six months and is leaning towards the lower band of the 52-week range of USD 7.72 to USD 33.00. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 34.50. We have valued the stock using the Price/Earnings-based relative valuation methodology and arrived at a target price of USD 13.51.
Considering the company's growth prospects, strategic expansion initiatives, associated risks, and current trading levels, we recommend a "Speculative Buy" rating on the stock at the current price of USD 10.98, up 2.04% as of November 08, 2021, 1:42 PM ET.
* The reference data in this report has been partly sourced from REFINITIV.
* All forecasted figures and industry information have been taken from REFINITIV.
* Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached.